PDT Partners, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$804,000
+1262.7%
151,956
+747.6%
0.05%
+1225.0%
Q4 2020$59,000
-10.6%
17,927
-9.0%
0.00%0.0%
Q2 2020$66,000
-86.1%
19,692
-77.6%
0.00%
-85.2%
Q1 2019$476,000
+199.4%
87,800
+64.4%
0.03%
+200.0%
Q4 2018$159,00053,4000.01%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders